Arcutis Biotherapeutics is a commercial-stage biopharmaceutical company focused on developing and commercializing topical and systemic treatments for dermatological diseases. Its portfolio centers on ZORYVE, a brand comprising roflumilast-based formulations (cream 0.3%, cream 0.15%, cream 0.05%, and foam 0.3%) approved for plaque psoriasis, seborrheic dermatitis, and atopic dermatitis. The company markets products in the United States and Canada and has licensing agreements for international markets.
Q2 FY2026 — expected 2026-08-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001787306-26-000018 | EDGAR | 101K words |
| 2025-02-25 | 2024-12-31 | 0001787306-25-000029 | EDGAR | 100K words |
| 2024-02-27 | 2023-12-31 | 0001787306-24-000031 | EDGAR | 97K words |
| 2023-02-28 | 2022-12-31 | 0001787306-23-000023 | EDGAR | 97K words |
| 2022-02-22 | 2021-12-31 | 0001787306-22-000009 | EDGAR | — |
| 2021-02-16 | 2020-12-31 | 0001628280-21-002272 | EDGAR | — |
| 2020-03-19 | 2019-12-31 | 0001787306-20-000005 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001787306-26-000051 | EDGAR | 22K words |
| 2025-10-28 | 2025-09-30 | 0001787306-25-000144 | EDGAR | 23K words |
| 2025-08-06 | 2025-06-30 | 0001787306-25-000124 | EDGAR | 21K words |
| 2025-05-06 | 2025-03-31 | 0001787306-25-000092 | EDGAR | 20K words |
| 2024-11-06 | 2024-09-30 | 0001787306-24-000153 | EDGAR | 24K words |
| 2024-08-14 | 2024-06-30 | 0001787306-24-000124 | EDGAR | 24K words |
| 2024-05-14 | 2024-03-31 | 0001787306-24-000079 | EDGAR | 18K words |
| 2023-11-03 | 2023-09-30 | 0001787306-23-000124 | EDGAR | 34K words |
| 2023-08-08 | 2023-06-30 | 0001787306-23-000077 | EDGAR | 30K words |
| 2023-05-09 | 2023-03-31 | 0001787306-23-000044 | EDGAR | 27K words |
| 2022-11-08 | 2022-09-30 | 0001787306-22-000071 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001787306-22-000051 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001787306-26-000049 | EDGAR | 3K words |
| 2026-07-16 | 0001628280-26-048469 | EDGAR | 1K words |
| 2026-02-25 | 0001787306-26-000017 | EDGAR | 3K words |
| 2025-12-08 | 0001787306-25-000147 | EDGAR | 1K words |
| 2025-10-28 | 0001787306-25-000142 | EDGAR | 3K words |
| 2025-08-06 | 0001787306-25-000122 | EDGAR | 3K words |
| 2025-06-17 | 0001787306-25-000096 | EDGAR | 1K words |
| 2025-05-06 | 0001787306-25-000091 | EDGAR | 3K words |
| 2025-04-10 | 0001787306-25-000058 | EDGAR | 1K words |
| 2025-02-25 | 0001787306-25-000028 | EDGAR | 3K words |
121 total filings indexed. 92 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001787306 |
| Ticker | ARQT |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.arcutis.com |
| Listed | 2020-01-31 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ARQT (~200 tokens, structured JSON with cryptographic provenance)